• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病:从体内到体外疾病模型

Von Willebrand Disease: From In Vivo to In Vitro Disease Models.

作者信息

de Boer Suzan, Eikenboom Jeroen

机构信息

Department of Internal medicine, division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Hemasphere. 2019 Sep 27;3(5):e297. doi: 10.1097/HS9.0000000000000297. eCollection 2019 Oct.

DOI:10.1097/HS9.0000000000000297
PMID:31942548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6919471/
Abstract

Von Willebrand factor (VWF) plays an essential role in primary hemostasis and is exclusively synthesized and stored in endothelial cells and megakaryocytes. Upon vascular injury, VWF is released into the circulation where this multimeric protein is required for platelet adhesion. Defects of VWF lead to the most common inherited bleeding disorder von Willebrand disease (VWD). Three different types of VWD exist, presenting with varying degrees of bleeding tendencies. The pathophysiology of VWD can be investigated by examining the synthesis, storage and secretion in VWF producing cells. These cells can either be primary VWF producing cells or transfected heterologous cell models. For many years transfected heterologous cells have been used successfully to elucidate many aspects of VWF synthesis. However, those cells do not fully reflect the characteristics of primary cells. Obtaining primary endothelial cells or megakaryocytes with a VWD phenotype, requires invasive procedures, such as vessel collection or a bone marrow biopsy. A more recent and promising development is the isolation of endothelial colony forming cells (ECFCs) from peripheral blood as a true-to-nature cell model. Alternatively, various animal models are available but limiting, therefore, new approaches are needed to study VWD and other bleeding disorders. A potential versatile source of endothelial cells and megakaryocytes could be induced pluripotent stem cells (iPSCs). This review gives an overview of models that are available to study VWD and VWF and will discuss novel approaches that can be considered to improve the understanding of the structural and functional mechanisms underlying this disease.

摘要

血管性血友病因子(VWF)在初级止血过程中发挥着至关重要的作用,并且仅在内皮细胞和巨核细胞中合成与储存。血管受损时,VWF会释放到循环系统中,这种多聚体蛋白是血小板黏附所必需的。VWF缺陷会导致最常见的遗传性出血性疾病——血管性血友病(VWD)。VWD存在三种不同类型,出血倾向程度各异。可通过检测VWF产生细胞中的合成、储存和分泌情况来研究VWD的病理生理学。这些细胞既可以是原发性VWF产生细胞,也可以是转染的异源细胞模型。多年来,转染的异源细胞已成功用于阐明VWF合成的诸多方面。然而,这些细胞并不能完全反映原代细胞的特性。要获得具有VWD表型的原代内皮细胞或巨核细胞,需要进行侵入性操作,如血管采集或骨髓活检。最近一个有前景的进展是从外周血中分离出内皮集落形成细胞(ECFCs)作为一种天然的细胞模型。另外,有多种动物模型可用,但存在局限性,因此,需要新的方法来研究VWD和其他出血性疾病。诱导多能干细胞(iPSC)可能是内皮细胞和巨核细胞的一个潜在通用来源。本综述概述了可用于研究VWD和VWF的模型,并将讨论一些新方法,这些方法可被视为有助于增进对该疾病潜在结构和功能机制的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/371103826623/hs9-3-e297-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/1b1fbee4614d/hs9-3-e297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/349c3cafcbf5/hs9-3-e297-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/371103826623/hs9-3-e297-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/1b1fbee4614d/hs9-3-e297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/349c3cafcbf5/hs9-3-e297-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2cf/6919471/371103826623/hs9-3-e297-g005.jpg

相似文献

1
Von Willebrand Disease: From In Vivo to In Vitro Disease Models.血管性血友病:从体内到体外疾病模型
Hemasphere. 2019 Sep 27;3(5):e297. doi: 10.1097/HS9.0000000000000297. eCollection 2019 Oct.
2
New development in von Willebrand disease.血管性血友病新进展。
Curr Opin Hematol. 2013 Sep;20(5):424-9. doi: 10.1097/MOH.0b013e328363c11f.
3
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.2003年的血管性血友病:迈向全面鉴定基因缺陷以实现正确诊断和治疗
Haematologica. 2003 Jan;88(1):94-108.
4
A human chimera for von Willebrand disease following bone marrow transplantation.骨髓移植后出现的血管性血友病人类嵌合体。
Am J Pediatr Hematol Oncol. 1993 Aug;15(3):338-42.
5
von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.2A型血管性血友病IIC、IID和IIE亚型:剪切应力作用下突变血管性血友病因子的一天。
Thromb Haemost. 2014 Jul 3;112(1):96-108. doi: 10.1160/TH13-11-0902. Epub 2014 Mar 6.
6
Diagnosis of von Willebrand disease.血管性血友病的诊断。
Haemophilia. 1998 Jul;4(4):654-60. doi: 10.1046/j.1365-2516.1998.440654.x.
7
Advances in the diagnosis and management of type 1 von Willebrand disease.1 型血管性血友病的诊断和治疗进展。
Expert Rev Hematol. 2011 Feb;4(1):95-106. doi: 10.1586/ehm.11.1.
8
Diagnosis of inherited von Willebrand disease: a clinical perspective.遗传性血管性血友病的诊断:临床视角
Semin Thromb Hemost. 2006 Sep;32(6):555-65. doi: 10.1055/s-2006-949661.
9
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.隐性严重1型和3型血管性血友病(VWD)、无症状杂合子携带者与血型O相关的血管性血友病因子缺乏症以及显性1型VWD的特征分析
Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401.
10
Von Willebrand's disease: case report and review of literature.血管性血友病:病例报告及文献综述
Pan Afr Med J. 2017 Jun 29;27:147. doi: 10.11604/pamj.2017.27.147.12248. eCollection 2017.

引用本文的文献

1
Approaches to induce the maturation process of human induced pluripotent stem cell derived-endothelial cells to generate a robust model.诱导人诱导多能干细胞衍生内皮细胞成熟过程的方法,以生成稳健的模型。
PLoS One. 2024 Feb 23;19(2):e0297465. doi: 10.1371/journal.pone.0297465. eCollection 2024.
2
Proteomic profiling of serum exosomes reveals acute phase response and promotion of inflammatory and platelet activation pathways in patients with heat stroke.血清外泌体的蛋白质组学分析揭示了热射病患者急性期反应,并促进了炎症和血小板激活途径。
PeerJ. 2023 Dec 13;11:e16590. doi: 10.7717/peerj.16590. eCollection 2023.
3
Development and evaluation of a bovine lung-on-chip (bLOC) to study bovine respiratory diseases.

本文引用的文献

1
Variability of von Willebrand factor-related parameters in endothelial colony forming cells.血管内皮祖细胞中血管性血友病因子相关参数的变异性。
J Thromb Haemost. 2019 Sep;17(9):1544-1554. doi: 10.1111/jth.14558. Epub 2019 Jul 22.
2
Transcriptional dynamics of pluripotent stem cell-derived endothelial cell differentiation revealed by single-cell RNA sequencing.单细胞RNA测序揭示的多能干细胞来源的内皮细胞分化的转录动力学
Eur Heart J. 2020 Mar 1;41(9):1024-1036. doi: 10.1093/eurheartj/ehz351.
3
Standardization of methods to quantify and culture endothelial colony-forming cells derived from peripheral blood: Position paper from the International Society on Thrombosis and Haemostasis SSC.
用于研究牛呼吸道疾病的牛肺芯片(bLOC)的开发与评估。
In Vitro Model. 2022;1(4-5):333-346. doi: 10.1007/s44164-022-00030-z. Epub 2022 Aug 17.
4
APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis.APOLD1 缺失导致涉及细胞连接、细胞骨架结构和 Weibel-Palade 小体的血管内皮功能障碍,同时破坏止血。
Haematologica. 2023 Mar 1;108(3):772-784. doi: 10.3324/haematol.2022.280816.
5
A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.一种纯合性深内含子变异导致血管性血友病因子缺乏和缺乏内皮细胞特异性分泌细胞器,Weibel-Palade 小体。
Int J Mol Sci. 2022 Mar 13;23(6):3095. doi: 10.3390/ijms23063095.
6
Therapeutic Potential of Endothelial Colony-Forming Cells in Ischemic Disease: Strategies to Improve their Regenerative Efficacy.内皮祖细胞在缺血性疾病中的治疗潜力:提高其再生疗效的策略。
Int J Mol Sci. 2020 Oct 7;21(19):7406. doi: 10.3390/ijms21197406.
外周血来源的内皮祖细胞定量及培养方法的标准化:国际血栓与止血学会科学与标准化委员会立场文件
J Thromb Haemost. 2019 Jul;17(7):1190-1194. doi: 10.1111/jth.14462. Epub 2019 May 22.
4
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.血小板型血管性血友病的血小板减少机制。
Haematologica. 2019 Jul;104(7):1473-1481. doi: 10.3324/haematol.2018.200378. Epub 2019 Jan 17.
5
Recent Advances in Endothelial Colony Forming Cells Toward Their Use in Clinical Translation.内皮祖细胞在临床转化应用方面的最新进展
Front Med (Lausanne). 2018 Oct 23;5:295. doi: 10.3389/fmed.2018.00295. eCollection 2018.
6
Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor.通过小干扰 RNA 介导的等位基因特异性抑制突变型血管性血友病因子,纠正血管性血友病因子的显性负性多聚化缺陷。
J Thromb Haemost. 2018 Jul;16(7):1357-1368. doi: 10.1111/jth.14140. Epub 2018 Jun 1.
7
Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.人诱导多能干细胞衍生的内皮细胞的炎症反应和屏障功能。
Stem Cell Reports. 2018 May 8;10(5):1642-1656. doi: 10.1016/j.stemcr.2018.03.012. Epub 2018 Apr 12.
8
Vwf K1362A resulted in failure of protein synthesis in mice.血管性血友病因子K1362A导致小鼠蛋白质合成失败。
Int J Hematol. 2018 Apr;107(4):428-435. doi: 10.1007/s12185-017-2394-y. Epub 2018 Feb 1.
9
Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome.Roifman 综合征患者 B 细胞和巨核细胞的分化异常。
J Allergy Clin Immunol. 2018 Aug;142(2):630-646. doi: 10.1016/j.jaci.2017.11.061. Epub 2018 Jan 31.
10
Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.血管性血友病患者 p.Pro2808Leufs*24 存在血小板和血浆血管性血友病因子的差异。
J Thromb Haemost. 2017 Jul;15(7):1403-1411. doi: 10.1111/jth.13722. Epub 2017 Jun 6.